Plain-English translation of NCT06216782 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This is an observational study that follows lung cancer patients who receive pre-surgery treatment (chemotherapy, immunotherapy, or targeted therapy) to understand how well these approaches work in everyday medical practice. Researchers will collect information from 2,000 patients with non-small cell or small cell lung cancer to learn which pre-surgery treatment approaches are most effective for different patient groups.
Current pre-surgery treatments for advanced lung cancer only improve long-term survival by about 5%, and researchers want to understand why. This study will examine real-world results from different treatment combinations to help doctors choose the best pre-surgery approach for individual patients and potentially improve outcomes.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to review and collect information about your lung cancer diagnosis, the pre-surgery treatment you received, and your health outcomes over time. You would need to attend follow-up visits as part of your regular cancer care, and researchers would track how well your treatment worked and whether you went on to have surgery. The study will continue tracking your health information for several years to understand long-term results.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China
Enrollment target
~2,000 participants
Started
December 2023
Primary completion
December 2033
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Peng Zhang, Ph.D.
Shanghai Pulmonary Hospital, Shanghai, China
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.